Taylor Devices
TAYD · NASDAQ
About TAYD
- Employees
- 136
- Headquarters
- North Tonawanda, New York
- Listed
- Nov 5, 1980
- Sector
- Industrials
- Industry
- Machinery
- Website
- taylordevices.com
TAYD key statistics
- Market cap
- 177.64M
- Price-earnings ratio
- 25.85
- Dividend yield
- —
- Average volume
- 47.26K
- Volume
- 18.11K
- Open price
- $53.80
- High today
- $55.10
- Low today
- $53.16
- 52 Week high
- $90.37
- 52 Week low
- $40.50
Taylor Devices (TAYD) at a glance
As of Oct 20, 2026, Taylor Devices (TAYD) shares are priced at $55.00, giving the company a market cap of 177.64M and a price-to-earnings ratio of 25.85.
Today the stock has traded between $53.16 and $55.10. The current price is 3.5% above the day's low and 0.2% below its high.
Volume so far is 18.11K shares, below the average of 47.26K shares a day.
Over the past year Taylor Devices has ranged from $40.50 to $90.37, and now sits 29% of the way up that range.
Taylor Devices met or beat analyst EPS estimates in 3 of the last 5 quarters. In Q3 FY26 it reported $0.14 per share against an estimate of $0.9384.
The average analyst price target is $71.40, 29.8% above the current price, from 1 recent ratings.
Analyst ratings
Latest rating from each analyst over the past 12 months
- Buy0.0%
- Hold100.0%
- Sell0.0%
- Low
- $70.70
- Now
- $55.00
- High
- $73.50
TAYD earnings
Earnings per share, reported against the analyst estimate
Beat the estimate in 3 of the last 5 quarters, by 0.0% on average.
- Q3 FY23: reported $0.47 per share against an estimate of $0.00
- Q3 FY24: reported $0.82 per share against an estimate of $0.00
- Q1 FY25: reported $0.85 per share against an estimate of $0.00
- Q2 FY26: reported $0.50 per share against an estimate of $0.7956
- Q3 FY26: reported $0.14 per share against an estimate of $0.9384
TAYD news
- Press releasePRNewswire
- Avi Kapoor
5 Stock Picks Last Week From Wall Street's Most Accurate Analysts
- Press releasePRNewswire
TAYLOR DEVICES ANNOUNCES FOURTH QUARTER AND FULL YEAR RESULTS INCLUDING RECORD HIGH FIRM ORDER BACKLOG FOR FISCAL YEAR 2026
- Press releasePRNewswire
TAYLOR DEVICES TO EXHIBIT AT THE FARNBOROUGH INTERNATIONAL AIRSHOW FOR THE FIRST TIME IN THE COMPANY'S HISTORY
12 Industrials Stocks Moving In Tuesday's Intraday Session
- Press releasePRNewswire
TAYLOR DEVICES ANNOUNCES THIRD QUARTER AND NINE-MONTH RESULTS INCLUDING RECORD HIGH NINE-MONTH SALES
- Press releasePRNewswire
TAYLOR DEVICES ANNOUNCES FISCAL YEAR 2026 SECOND QUARTER AND FIRST HALF RESULTS INCLUDING RECORD HIGH SALES FOR BOTH THE SECOND QUARTER AND FIRST HALF
- Press releasePRNewswire
TAYLOR DEVICES ANNOUNCES FIRST QUARTER RESULTS
Similar companies
Companies in the same industry as Taylor Devices
Most active stocks
Highest trading volume today
- EARIEntertainment Arts Research$0.0003−16.67%
- SEIISharing Economy International$0.0004+100.00%
- NWGLCL Workshop Group$0.1522+27.90%
- TMSHTrans Global Assets$0.0002+0.00%
- AEFIAmerican EcoFuels$0.0007+0.00%
- CBDW1606$0.0002+0.00%
- FITYFifty 1 Labs$0.0001−66.67%
- PRSOPeraso$0.5914+54.13%
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- FRTTFort Technology$0.7121+32.63%
- CBDLCBD Life Sciences$0.0002−25.00%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.